




Current research programs are directed to elaboration of 
strategies of effective prognosis, prevention and treatment of 
functional disorders of the central nervous system. It espe-
cially refers to dementia, in particular those developing with 
Alzheimer’s disease, Hallervorden-Spatz disease, Parkinson’s 
disease, since their pathogenic mechanisms are associated with 
neurodegenerative processes [8, 16]. The most widely spread 
sign for the majority of neurodegenerative disorders is an exces-
sive formation of oxygen reactive forms due to oxidative stress, 
causing damage and loss of neuronal cells [9]. Under conditions 
of neurodestruction progress the activity of the antioxidant sys-
tem decreases and formation of free radicals increases, inducing 
damage of tissues, changing oxidation-reduction state of cells 
followed by further activation of redox-sensitive genes. There-
fore, oxidative stress is a cause and a leading component of 
many pathological processes of the central nervous system and 
neurodegenerative diseases in particular [14, 21].
The brain is the most sensitive to oxidative damage [13]. 
Glutathione system plays an important role in realization of 
anti-radical protection of neurons. Coordinated action of all its 
components (reduced glutathione, glutathione peroxidase, glu-
tathione reductase, sulfhydryl groups) promotes restoration of 
an optimal level of peroxide compounds and maintenance of 
the pro-antioxidant balance [1, 5]. Moreover, glucose-6-phos-
phate dehydrogenase, possessing a key position in glutathione 
metabolism, is a source of pentose essential for the synthesis 
and reparation of DNA. Thus, the degree of glutathione system 
damage is closely connected with cytotoxic effects. At the same 
time, disorders in the glutathione system take a leading role in 
realization of neurodegeneration mechanisms caused by oxida-
tive stress [4]. 
Results of experimental and clinical studies in recent years 
enable to consider that activation of renin-angiotensin system 
(RAS) of the brain is one of pathogenic chains of oxidative dam-
age of the neuron cellular membranes due to increased genera-
tion of oxygen reactive forms [6, 22]. Considering the fact that 
due to establishment of non-cardiovascular effects of RAS, and 
availability of the central neurotropic effects in particular (abil-
ity to reduce oxidative stress and apoptosis), the possibilities of 
pharmacological blockers of RAS under conditions of develop-
ment of neurodegenerative changes in the brain neurons are of 
a special interest. 
Objective of the work is to study enalapril effect, a blocker of 
renin-angiotensin system, on glutathione chain of the antioxi-
dant system of the cerebral cortex and hippocampus of rats with 
experimental neurodegeneration.
Material and methods. The experiments were conducted 
on nonlinear albino male rats 0,18-0,20 kg of the body weight, 
kept under standard vivarium conditions at the temperature of 
18-22 °C and relative humidity 40-60 %, fed on balanced food 
allowance and free access to water. All the experiments with 
animals were conducted according the main principles of the 
European Convention for the Protection of Vertebrate Animals 
used for Experimental and other Scientific Purposes (Strasburg, 
1986). All the rats were randomized into two groups: 1 – control 
group; 2 – group with neurodegeneration model. Considering 
the common recognition of cholinergic hypothesis in patho-
genesis of neurodegenerative changes in the central nervous 
system the experiments were conducted under conditions of 
scopolamine-induced damage of the brain [12]. To create the 
model scopolamine hydrochloride (Sigma, USA) was injected 
intraperitoneally (i/p) in the dose of 1 mg/kg of the body weight 
in the form of 0,01 % water solution, once a day during 27 days. 
The rats from the control group received physiological solution 
only in the analogical regimen and experimental conditions.
On the 28th day the rats with modeled pathology were random-
ized into two groups: І – i/p administration of enalapril (Zdoro-
vye, Ukraine) in the dose of 1 mg/kg and ІІ – 1 ml of saline 
only during 14 days [18]. The control rats received 1 ml of sa-
line since the 28th day. Euthanasia of the animals was performed 
under light ether narcosis. At a cold temperature the brain was 
removed, carefully washed with cool 0,9 % NaCl solution, and 
the cerebral cortex and hippocampus were isolated according to 
the coordinates of the stereotaxic atlas [19], since these parts 
of the brain are the first to suffer in case of neurodegenerative 
processes [3, 20]. Cytoplasmic fraction was isolated by means 
of the method of differentiation centrifuging of homogenate of 
the cerebral cortex and hippocampus on the refrigerator centri-
fuge at 1000 g 10 min, then 1400 g 10 min at a temperature of 
4 °С. To assess the state of the antioxidant system of the cerebral 
cortex and hippocampus the contents of sulfhydryl (SH-) groups 
[10], reduced glutathione (G-SH) and activity of glutathione-
reductase (GR) [EC 1.6.4.2], glutathione-peroxidase (GP) [EC 
1.11.1.9], glucose-6-phosphate dehydrogenase (G-6-PDH) [EC 
1.1.1.49] were determined by means of certain methods [15]. 
Lowry protein assay determined the amount of protein in speci-
mens [7].
The results of the study were statistically processed by means 
of Student t-criterion. Distribution of values in samples was pre-
liminary checked in order to prove an adequate method of statis-
tical assessment of a mean difference between the groups of the 
study. According to Shapiro-Wilk criterion the data concerning 
distribution deviation in samples from that of the norm were not 
obtained (p>0,05). Taking into account the above-mentioned ap-
plication of Student t-criterion was considered to be sufficient to 
obtain valid conclusions. At the same time, to prove reliability 
of conclusions Mann-Whitney non-parametric comparison cri-
terion was applied, which showed similar results of calculations 
by means of Student t-criterion concerning p value. Therefore, 
р≤0,05 was considered to be a sufficient level of discrepancy 
probability.
Results and their discussion. Glutathione system takes a 
leading role in maintenance of SH - S-S exchange in the tis-
sues at the expense of transformation of reduced glutathione 
form into oxidized one essential for performance of such vital 
processes in the cells as functioning of membranous structures, 
cellular skeleton and cellular division. Exhaustion of functional 
possibilities of glutathione system results in activation of free 
radical oxidation, increased permeability of the cellular mem-
branes for Са2+ ions, activation of phospholipase and endonucle-
ase, which in its turn is a cause of free radical or enzymatic dam-
age of DNA molecules [2].
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The present study investigates the dynamics of G-SH changes 
in the cerebral cortex and hippocampus (Table). Thus, in com-
parison with the control group, the content of G-SH in rats with 
scopolamine-induced neurodegeneration 63,4 and 36,6 % de-
creased in the cerebral cortex and hippocampus respectively. 
Such differences are most likely caused by increased use of 
G-SH for inactivation of excessive amount of free radicals in the 
damaged neurons of the examined cerebral structures and inhi-
bition of the process of G-SH regeneration from the oxidized 
form. At the same time, a decreased activity of the enzyme of 
NADPH-dependent GR participating in the process of antiox-
idant protection is found – 46,4 % in the cerebral cortex and 
40,5 % - in the hippocampus. 
In rats with neurodegeneration GP activity, which uses G-SH 
for neutralization of hydrogen peroxide and other hydroxyper-
oxides, was lower than that of the control group: 30,4 % – in the 
cerebral cortex; and 32, 9 % – in the hippocampus. The content 
of SН-groups contained in glutathione and providing biochemi-
cal reactions of metabolism and maintenance of membranous 
functions decreased as well: 30,6 % in the cerebral cortex and 
22,3 % – in the hippocampus. 
One of the ways to adapt the metabolism of cerebral tissues 
to hypoxic conditions is activation of pentose phosphate way of 
oxidation. Therefore, we have examined G-6-PDH activity in 
the examined cerebral structures of rats. Decreased activity of 
G-6-PDH was found to be 21,6 and 27,9 % in the cerebral cortex 
and hippocampus respectively in rats with scopolamine-induced 
neurodegeneration in comparison with the indices in the control 
group. 
Further analysis demonstrated that after administration of 
enalapril the indices of antioxidant protection in the brain in-
creased in rats with neurodegeneration. Comparison of the data 
obtained in the modeled pathology with the indices of rats sub-
jected to enalapril determined increased content of G-SH in the 
cerebral cortex 1,8 times as much and in the hippocampus – 1,2 
times. Under enalapril effect the content of SH-groups in the 
cerebral cortex and hippocampus increased 1,3 and 1,1 times 
respectively. Increasing of G-SH content is likely to occur at the 
expense of its intensified regeneration from the oxidized form in 
the tissues of the cerebral cortex and hippocampus. A positive 
effect of enalapril was characterized by an increased activity of 
GR in the cerebral cortex 1,7 times as much, and 1,6 times – in 
the hippocampus. 
In view of the absence of significant differences in the activity 
of G-6-PDH in the enalapril group compared to the pathology, 
the cause of the detected changes in the investigated structures 
can be considered to be the involvement of this enzyme in the 
pentosephosphate pathway of carbohydrate metabolism to stabi-
lize oxidation-reduction processes in the brain. One of the func-
tions of pentose phosphate way of carbohydrate metabolism 
is supply of NADPH reduced equivalents essential for energy 
production and restoration of oxidized glutathione in the brain.
Therefore, the conducted experimental studies determined 
that enalapril increases activity of the brain antioxidant system 
under conditions of development of Scopolamine-induced neu-
rodegeneration in rats. Increase of the antioxidant protection is 
first of all caused by angiotensin II (AII) inhibition – the main 
RAS effector. In addition to powerful vasoconstriction it stimu-
lates NADPH-oxidase, which excessive production plays a key 
role in the development of oxidative and inflammatory process-
es, intensifies neuron susceptibility and induces neuronal mito-
chondrial dysfunction [17]. A positive effect of enalapril can be 
explained by the fact of formation of other kinds of angiotensin 
with decreased activity of AII formation - A-1-7, AIII, AIV in 
particular [11]. These peptides cause additional stimulation of 
appropriate receptors, and thus promote additional vasodilation, 
anti-proliferation action and regeneration of tissues. At the same 
time, cerebral circulation improves due to systemic vasocon-
striction effects of AII, and the processes of antioxidant protec-
tion, essential for cerebral functioning, intensify. 
Conclusions.
1. Scopolamine-induced neurodegeneration reduces the content 
of reduced glutathione, sulfhydryl groups, activity of glutathi-
one reductase, glutathione peroxidase and glucose-6-phosphate 
Table. Enalapril effect on the indices of glutathione system in cytosolic fraction 
of rats with Scopolamine-induced neurodegeneration (М±m, n=7)







Cerebral cortex 7,373±0,600 2,698±0,339* 4,942±0,283*,**
Hippocampus 6,839±1,018 4,247±0,589* 5,183±0,784**
Glutathione peroxidase
(nmol ГSSГ/(min of mg 
of protein))
Cerebral cortex 143,174±13,988 99,594±7,250* 121,880±10,545
Hippocampus 131,460±15,549 88,277±10,931* 110,519±10,066
Glutathione reductase
(nmol NADPH /(min of mg 
of protein)
Cerebral cortex 3,710±0,486 1,995±0,404* 3,475±0,270**
Hippocampus 3,464±0,461 2,062±0,441* 3,317±0,215**
Glucose-6-phosphate dehydro-
genase (nmol/(min of mg 
of protein)
Cerebral cortex 6,286±0,110 4,938±0,481* 5,199±0,677
Hippocampus 4,834±0,366 3,475±0,495* 3,594±0,274*
Sulfhydryl groups (nmol/(min 
of mg of protein)
Cerebral cortex 72,813±2,357 50,548±2,907* 63,945±3,613**
Hippocampus 70,575±3,795 54,834±3,101* 59,276±1,354**
notes: * – significant difference compared to that of the control group; 





dehydrogenase in the cerebral cortex and hippocampus, which 
is indicative of inhibition of the antioxidant protection system. 
2. Administration of enalapril, a blocker of renin-angiotensin 
system, increases the content of reduced glutathione and sulfhy-
dryl-groups, activity of glutathione-dependent enzyme – gluta-
thione reductase in the cerebral cortex and hippocampus of rats 
with scopolamine-induced neurodegeneration. 
3. Improvement of the antioxidant protection glutathione chain 
in the cerebral cortex and hippocampus is indicative of enalapril 
ability to inhibit pathogenic mechanisms of neurodegenerative 
processes caused by tissue renin-angiotensin system in the cen-
tral nervous system. 
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SUMMARY
ENALAPRIL EFFECT ON GLUTATHIONE CHAIN OF 
THE ANTIOXIDANT SYSTEM OF THE BRAIN IN RATS 
WITH SCOPOLAMINE-INDUCED NEURODEGENERA-
TION 
Kmet O., Filipets N., Kmet T., Hrachova T., Vepriuk Y.
Higher State Educational Establishment of Ukraine «Bukovin-
ian State Medical University», Chernivts, Ukraine
Objective of the work is to study enalapril effect, a blocker of 
renin-angiotensin system, on glutathione chain of the antioxi-
dant system of the cerebral cortex and hippocampus of rats with 
experimental neurodegeneration. 
The experiments were conducted on nonlinear laboratory 
albino male rats with their body weight of 0,18-0,20 kg. The 
model of neurodegeneration was created by means of intra-
peritoneally administration of scopolamine hydrochloride 
(Sigma, USA) during 27 days in the dose of 1 mg/kg. Since 
the 28th day of the experiment enalapril (Zdorovye, Ukraine) 
was introduced intraperitoneally in the dose of 1 mg/kg in 1 
ml of physiological solution once a day during 14 days.
The content of reduced glutathione in male rats with scopol-
amine-induced neurodegeneration after introduction of enalapril 
increased in the cerebral cortex 1,8 times as much, and in the 
hippocampus – 1,2 times. Under enalapril effect the content of 
sulfhydryl groups increased in the cerebral cortex and hippo-
campus 1,3 and 1,1 times respectively. A positive effect of enala-
pril was characterized by an increased activity of glutathione 
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reductase in the cerebral cortex 1,7 times as much, and 1,6 times 
– in the hippocampus. 
Thus, enalapril improves the indices of glutathione chain of 
the antioxidant system of the cerebral cortex and hippocampus, 
which is indicative of its neuroprotective ability under condi-
tions of scopolamine-induced damage and development of neu-
rodegenerative processes in rats. 
Keywords: scopolamine-induced neurodegeneration, brain, 
enalapril, glutathione chain.
РЕЗЮМЕ
ВЛИЯНИЕ ЭНАЛАПРИЛА НА ГЛУТАТИОНОВОЮ 
ЦЕПЬ АНТИОКСИДАНТНОЙ СИСТЕМЫ МОЗГА 
КРЫС СО СКОПОЛАМИН-ИНДУЦИРОВАННОЙ 
НЕЙРОДЕГЕНЕРАЦИЕЙ 
Кметь О.Г., Филипец Н.Д., Кметь Т.И., Грачева Т.И., 
Вепрюк Ю.М.
Высшее государственное учебное заведение Украины «Бу-
ковинский государственный медицинский университет», 
Черновцы, Украина
Цель исследования - изучить влияние блокатора ренин-
ангиотензиновой системы эналаприла на глутатионовою 
цепь антиоксидантной системы коры головного мозга и 
гиппокампа крыс с экспериментальной нейродегенерацией. 
Эксперименты проводили на нелинейных лабораторных 
белых крысах самцах массой 0,18-0,20 кг. Модель нейро-
дегенерации создавали внутрибрюшинным введением в 
течение 27 дней скополамина гидрохлорида (Sigma, США) 
в дозе 1 мг/кг. Начиная с 28 суток эксперимента, эналаприл 
вводили внутрибрюшинно в дозе 1 мг/кг в 1 мл физиологи-
ческого раствора - один раз в день в течение 14 дней. 
У крыс самцов со скополамин-индуцированной ней-
родегенерацией после введения эналаприла в коре го-
ловного мозга увеличивалось содержание глутатиона 
восстановленного в 1,8 раза и в гиппокампе - в 1,2 раза. 
Под влиянием эналаприла содержание сульфгидрильных 
групп повышалось в коре головного мозга и гиппокампе 
в 1,3 и 1,1 раза, соответственно. Положительное влияние 
эналаприла характеризовалось повышением активности 
глутатион-редуктазы в коре в 1,7 раза и в гиппокампе - в 
1,6 раза. 
Таким образом, эналаприл улучшает показатели глута-
тионовой цепи антиоксидантной системы коры головного 
мозга и гиппокампа, что указывает на его нейропротек-
торную способность в условиях скополамин-индуциро-
ванного повреждения и развития нейродегенеративных 
процессов у крыс.
reziume
enalaprilis gavlena skopolamin-inducirebuli 
neirodegeneraciis mqone virTagvebis tvinis an-
tioqsidaciuri sistemis glutaTionur jaWvze
o.kmeti, n.filipeci, t.kmeti, t.graCova, i.vepriuki
bukovinis saxelmwifo samedicino universiteti, 
Cernovci, ukraina
kvlevis mizans warmoadgenda renin-angiotenzi-
nis sistemis blokatoris – enalaprilis gavle-
nis Sefaseba Tavis tvinis qerqis da hipokampis 
antioqsidaciuri sistemis glutaTionur jaWvze 
virTagvebSi eqsperimentuli neirodegeneraciiT.
eqsperimentebi Catarda 0,18-0,20 kg wonis labo-
ratoriul araxazovan mamr TeTr virTagevebze. 
neirodegeneraciis modeli iqmneboda 27  dRis 
ganmavlobaSi intraperitoneulad skopolaminis 
hidroqloridis SeyvaniT (Sigma, США), doziT 1 mg/
kg. eqsperimentis 28-e dRidan 14  dRis ganmavloba-
Si, dReSi erTxel, intraperitoneulad Seiyvanebo-
da enalaprili, doziT 1 mg/kg 1 ml fiziologiur 
xsnarSi.
mamr virTagvebSi skopolamin-inducirebuli 
neirodegeneraciiT enalaprilis Seyvanis Semdeg 
Tavis tvinis qerqSi glutaTionis Semcveloba 
izrdeboda 1,8-jer, hipokampSi – 1,2-jer. enalapri-
lis gavleniT sulfhidriluri jgufebis Semcv-
eloba Tavis tvinis qerqsa da hipokampSi izrde-
boda, Sesabamisad, 1,3-jer da 1,1-jer. enalaprilis 
dadebiTi gavlena xasiaTdeboda glutaTion-
reduqtazas aqtivobis gazrdiT Tavis tvinis qer-
qSi 1,7-jer, hipokampSi – 1,6-jer.
amrigad, enalaprili aumjobesebs Tavis tvinis 
qerqis da hipokampis antioqsidaciuri siste-
mis glutaTionuri jaWvis maCveneblebs, rac 
miuTiTebs mis neiroproteqtorul SeasZle-
blobaze skopolamin-inducirebuli dazianebebis 
da neirodegeneraciuli procesebis ganviTarebis 
pirobebSi virTagvebSi.
